Page last updated: 2024-08-24

carbenoxolone sodium and cytarabine

carbenoxolone sodium has been researched along with cytarabine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Akl, H; Bene, MC; Bourgeais, J; Brossaud, J; Dakik, H; Domenech, J; El-Sabban, M; Foucault, A; Gallay, N; Gouilleux, F; Gyan, E; Hamard, S; Herault, O; Hleihel, R; Kouzi, F; Le Nail, LR; Mazurier, F; Picou, F; Ravalet, N; Rouleux-Bonnin, F; Roux, B; Zibara, K	1

Other Studies

1 other study(ies) available for carbenoxolone sodium and cytarabine

Article	Year
Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells. Oncogene, 2020, Volume: 39, Issue:6 Topics: Animals; Anti-Ulcer Agents; Antimetabolites, Antineoplastic; Apoptosis; Carbenoxolone; Cell Proliferation; Cytarabine; Drug Resistance, Neoplasm; Drug Therapy, Combination; Gap Junctions; Humans; Leukemia, Myeloid, Acute; Mesenchymal Stem Cells; Mice; Mice, Inbred NOD; Mice, SCID; Tumor Cells, Cultured; Tumor Microenvironment; Xenograft Model Antitumor Assays	2020

Article

Year

Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells.

Oncogene, 2020, Volume: 39, Issue:6

Topics: Animals; Anti-Ulcer Agents; Antimetabolites, Antineoplastic; Apoptosis; Carbenoxolone; Cell Proliferation; Cytarabine; Drug Resistance, Neoplasm; Drug Therapy, Combination; Gap Junctions; Humans; Leukemia, Myeloid, Acute; Mesenchymal Stem Cells; Mice; Mice, Inbred NOD; Mice, SCID; Tumor Cells, Cultured; Tumor Microenvironment; Xenograft Model Antitumor Assays

2020